Lead party: FDC Limited (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Fair Deal Corporation Pharmaceutical SA (Pty) Ltd (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: South Africa
Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Equity · Deal amount: US$385,260 · Equity stake: 0.44% · Implied EV: US$875,591
Lead investor/buyer: FDC Limited · Investors/buyers: FDC Limited
Legal advisers: not identified in the source record.
Source: announced 17 July 2020. Original announcement: marketscreener.com.


